Publications by authors named "F Nurwidya"
Background: Ovarian cancer patients often face poor nutritional status, with body composition (BC) serving as a significant prognostic indicator. Skeletal muscle mass (SMM) and fat-free mass (FFM) are crucial predictors of both survival and hospitalization duration. Increasing protein intake has been linked to improvements in SMM and FFM.
View Article and Find Full Text PDFArticle Synopsis
- * 93 healthcare providers studied showed a significant increase in SARS-CoV-2 antibody levels three months post-booster, rising from a median of 1.7 U/mL to 9540 U/mL.
- * Findings suggest that the heterologous Moderna booster not only boosts antibody response but also results in mostly mild COVID-19 symptoms among those who contract the virus afterwards.
The heterogeneity of the lung microbiome and its alteration are prevalently seen among chronic lung diseases patients. However, studies to date have primarily focused on the bacterial microbiome in the lung rather than fungal composition, which might play an essential role in the mechanisms of several chronic lung diseases. It is now well established that spp.
View Article and Find Full Text PDFArticle Synopsis
- A study on the long-term effects of COVID-19 in Indonesia found that 66.5% of survivors reported persistent symptoms, notably fatigue, cough, and muscle pain.
- The research was conducted through an online questionnaire among adult Indonesians who had recovered from the virus, with a focus on the correlation between health conditions and quality of life.
- Results indicated pneumonia as the most significant factor linked to persistent COVID-19 syndrome, highlighting the need for additional research to better understand and mitigate its impacts on health and well-being.
Indonesia is among the top three countries globally with the highest tuberculosis burden. During the past decades, Indonesian health authorities have struggled to improve tuberculosis care quality in health care facilities by optimizing the regulation and strengthening the private sector contributions. The coronavirus disease 2019 (COVID-19) pandemic has hardly affected the Indonesian health care system, including the National Tuberculosis Control Program.
View Article and Find Full Text PDF